Miguel Marino

Affiliation: Department of Family Medicine at Oregon Health & Science University

Educational Background: PhD, Biostatistics, Harvard University; MS and BS, Mathematics, University of California at Los Angeles

Miguel Marino is a Mexican-American biostatistician and associate professor of biostatistics in the department of family medicine at Oregon Health & Science University (OHSU) with a secondary appointment in the OHSU-PSU School of Public Health. He earned his undergraduate degree in mathematics from the University of California at Los Angeles (UCLA), his MS in biostatistics from UCLA, and his PhD in biostatistics from Harvard University.

Before joining OHSU, Marino was a Yerby Postdoctoral Fellow at Harvard University. He maintains a broad statistical research program that focuses on the intersection of primary care and public health studies. His research uses novel statistical methodology to address complexities associated with the use of electronic health records (EHRs) for critical community and primary care research questions in health policy, health disparities, preventive service utilization, and health insurance monitoring. Marino currently studies how to validate EHRs as a reliable source for pragmatic trials and observational cohort studies. He is funded by several agencies—including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality, and US Centers for Disease Control and Prevention—and has more than 130 peer-reviewed publications in scientific journals.

Since 2013, Marino has been the statistical editor for the Annals of Family Medicine. He also has served on NIH, Patient-Centered Outcomes Research Institute, and American Heart Association study sections. He formerly served as president of the ASA Oregon Chapter and currently serves as the publications officer for the Health Policy Statistics Section.

Marino’s contributions to the field were recognized in 2017 when he received the New Investigator Research Award by the North American Primary Care Research Group and in 2020 when he was selected by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar.